We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$484M
AUM Growth
+$6.33M
Cap. Flow
-$15.1M
Cap. Flow %
-3.11%
Top 10 Hldgs %
33.62%
Holding
129
New
9
Increased
21
Reduced
67
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 26.5%
2 Industrials 19.24%
3 Technology 16.19%
4 Energy 9.31%
5 Utilities 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAS
126
DELISTED
American Capital Ltd
ACAS
-107,451
Closed -$1.93M

Similar funds

John G. Ullman & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, John G. Ullman & Associates held 129 positions worth $484M, up 1.3% from $477M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

John G. Ullman & Associates withdrew a net $15.1M in Q1 2017, closing 12 positions and reducing 67 holdings. Its most notable exit was St Jude Medical, an estimated $5.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Technology.

Against the trend, John G. Ullman & Associates opened a new position in Conduent worth $1.56M.

  • John G. Ullman & Associates's largest Q1 2017 buy was Conduent: 92,776 shares worth $1.56M.
  • John G. Ullman & Associates added most to ExxonMobil in Q1 2017, an estimated $3.88M increase.
  • John G. Ullman & Associates's biggest Q1 2017 reduction was Corning, cutting an estimated $4.34M.
  • John G. Ullman & Associates fully exited St Jude Medical in Q1 2017, selling an estimated $5.9M.
  • John G. Ullman & Associates's ten largest holdings make up 34% of its $484M portfolio in Q1 2017.
  • John G. Ullman & Associates opened 9 new positions and closed 12 in Q1 2017.
  • John G. Ullman & Associates's portfolio value rose 1.3% quarter-over-quarter to $484M.

Based on John G. Ullman & Associates's 13F filing for Q1 2017, filed 25 Apr 2017.